Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?

PHASE1CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 18, 2021

Study Completion Date

September 18, 2021

Conditions
SchizophreniaDual DiagnosisPsychotic DisorderCannabis Use Disorder
Interventions
DRUG

Marijuana

Smoked plant with THC

DRUG

Dronabinol

Capsule with THC

DRUG

Placebo

Capsule with no active ingredient

Trial Locations (2)

03756

Dartmouth Hitchcock Medical Center, Lebanon

05401

University of Vermont, Burlington

All Listed Sponsors
collaborator

Columbia University

OTHER

collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

Massachusetts Institute of Technology

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Nathan Kline Institute for Psychiatric Research

OTHER

collaborator

University of Vermont

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01964404 - Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? | Biotech Hunter | Biotech Hunter